-
Je něco špatně v tomto záznamu ?
Safety and Pharmaceutical Evaluation of a Novel Natural Polymer, Ocicum, as Solubility and Dissolution Enhancer in Solid Dispersion
M. Manzoor, SA. Raza, MH. Asim, NI. Bukhari, S. Arshad, U. Zafar
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2009
PubMed Central
od 2004
Europe PubMed Central
od 2004
ProQuest Central
od 2004-01-01
Open Access Digital Library
od 2004-01-01
Open Access Digital Library
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2004
PubMed
35890167
DOI
10.3390/ph15070869
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Plant mucilages are commonly employed as excipients in pharmaceutical manufacturing. Ocimum basilicum (Lamiaceae family), a source of hydrophilic mucilage referred herein as Ocicum, was evaluated for the solubility enhancer of a model drug, aceclofenac, in solid dispersions prepared using different methods. Polymer was extracted from O. basilicum and solid dispersions of aceclofenac were fabricated with Ocicum or Poloxamer 407 using polymer-to-drug ratios of 1:1, 1:2 and 1:3 utilizing solvent evaporation, lyophilization and melt methods. Ocicum was evaluated for its safety via acute toxicity study including different biochemical and hematological parameters including liver and kidney profiles. Moreover, different characterization studies including melting-point, Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM), differential scanning calorimetry (DSC) and differential thermal analysis (TGA) were used for evaluation of polymer and solid dispersions. Furthermore, solubility and dissolution studies were performed to confirm solubility enhancement. Ocicum was found to be safer, and different characterization studies confirmed the purity of the compounds. In addition, Ocicum exhibited up to 6.27-fold enhanced solubility as compared to pure aceclofenac; similarly, 4.51-fold increased solubility by the synthetic polymer in their respective solid dispersions was shown. Furthermore, Ocicum-based solid dispersions showed substantial improvement in dissolution of aceclofenac. Therefore, it can be concluded from the above-mentioned results that Ocicum might be used as an economical natural oral delivery carrier alternative to the synthetic polymers.
College of Pharmacy University of Sargodha Sargodha 40100 Pakistan
Institute of Pharmacy Lahore College for Women University Lahore 54000 Pakistan
Punjab University College of Pharmacy University of the Punjab Lahore 54000 Pakistan
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22023722
- 003
- CZ-PrNML
- 005
- 20221031095109.0
- 007
- ta
- 008
- 221010s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ph15070869 $2 doi
- 035 __
- $a (PubMed)35890167
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Manzoor, Mobina $u Punjab University College of Pharmacy, University of the Punjab, Lahore 54000, Pakistan $u Institute of Pharmacy, Lahore College for Women University, Lahore 54000, Pakistan $1 0000000328324245
- 245 10
- $a Safety and Pharmaceutical Evaluation of a Novel Natural Polymer, Ocicum, as Solubility and Dissolution Enhancer in Solid Dispersion / $c M. Manzoor, SA. Raza, MH. Asim, NI. Bukhari, S. Arshad, U. Zafar
- 520 9_
- $a Plant mucilages are commonly employed as excipients in pharmaceutical manufacturing. Ocimum basilicum (Lamiaceae family), a source of hydrophilic mucilage referred herein as Ocicum, was evaluated for the solubility enhancer of a model drug, aceclofenac, in solid dispersions prepared using different methods. Polymer was extracted from O. basilicum and solid dispersions of aceclofenac were fabricated with Ocicum or Poloxamer 407 using polymer-to-drug ratios of 1:1, 1:2 and 1:3 utilizing solvent evaporation, lyophilization and melt methods. Ocicum was evaluated for its safety via acute toxicity study including different biochemical and hematological parameters including liver and kidney profiles. Moreover, different characterization studies including melting-point, Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM), differential scanning calorimetry (DSC) and differential thermal analysis (TGA) were used for evaluation of polymer and solid dispersions. Furthermore, solubility and dissolution studies were performed to confirm solubility enhancement. Ocicum was found to be safer, and different characterization studies confirmed the purity of the compounds. In addition, Ocicum exhibited up to 6.27-fold enhanced solubility as compared to pure aceclofenac; similarly, 4.51-fold increased solubility by the synthetic polymer in their respective solid dispersions was shown. Furthermore, Ocicum-based solid dispersions showed substantial improvement in dissolution of aceclofenac. Therefore, it can be concluded from the above-mentioned results that Ocicum might be used as an economical natural oral delivery carrier alternative to the synthetic polymers.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Raza, Syed Atif $u Punjab University College of Pharmacy, University of the Punjab, Lahore 54000, Pakistan
- 700 1_
- $a Asim, Mulazim Hussain $u College of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan $1 0000000319109615
- 700 1_
- $a Bukhari, Nadeem Irfan $u Punjab University College of Pharmacy, University of the Punjab, Lahore 54000, Pakistan $1 0000000157109574
- 700 1_
- $a Arshad, Shumaila $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Charles University, 50005 Hradec Králové, Czech Republic
- 700 1_
- $a Zafar, Uzma $u Punjab University College of Pharmacy, University of the Punjab, Lahore 54000, Pakistan
- 773 0_
- $w MED00184066 $t Pharmaceuticals (Basel, Switzerland) $x 1424-8247 $g Roč. 15, č. 7 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35890167 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20221010 $b ABA008
- 991 __
- $a 20221031095107 $b ABA008
- 999 __
- $a ind $b bmc $g 1853993 $s 1175010
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 15 $c 7 $e 20220714 $i 1424-8247 $m Pharmaceuticals $n Pharmaceuticals (Basel) $x MED00184066
- LZP __
- $a Pubmed-20221010